15.000 patients included in U-CAN


At the end of 2017, more than 15.000 patients had consented to participate in U-CAN since the start of the sample collection in 2010.

In Uppsala, both hematological malignancies and breast cancer surpassed 1000 patients included since the start, which also colorectal cancer in Umeå did. The highest number of new inclusions during 2017 was within the prostate cancer diagnosis in Umeå (537 patients), followed by the diagnosis areas brain cancer in Uppsala and lung cancer in Gävle (both included 290 patients each). The newly formed U-CAN diagnosis area esophagus- and gastric cancer in Uppsala, included 8 patients with these relatively rare diseases before the end of the year.

See the detailed statistics here.

All news items